Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Antibiotics for Shoulder PJI
NCT04636125Phase 3Unknown
- Sponsor
- Rothman Orthopaedics
- Start
- Sep 2019
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of doxycycline in periprosthetic joint infection (PJI), sponsored by Rothman Orthopaedics. Primary endpoint: Rate of Postoperative Infections at 1 year. Status: unknown.
02
Drugs
doxycycline
03
Conditions
periprosthetic joint infection (PJI)
Beyond the preview
Go deeper on NCT04636125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04636125.